Zika Virus, Pregnancy and Sex: Up-to-Date Information for Los Angeles Health Care Providers
The Webinar is currently under review
The archived webinar has been approved for
AMA PRA Category 1 Credit™
The webinar was recorded on 3/15/16. Original release date: 3/18/16. Review date: 5/23/16. Termination date: 3/14/17
This webinar is designed for all health care professionals in Los Angeles County-– particularly those providers who care for women who are pregnant or trying to become pregnant and those who care for patients presenting with illness following travel. Zika virus outbreaks in the Americas and elsewhere pose a potential risk to travelers, particularly pregnant women. Experts in public health and obstetrics and gynecology will share current information on Zika virus disease, implications for travelers and pregnant women, diagnostic testing, and what can be done to reduce the risk of transmission. Learn what resources your local health department can provide regarding education, testing, and consultation.
Laurene Mascola, MD, MPH, FAAP (moderator).
Chief, Acute Communicable Disease Control Program, Los Angeles County Department of Public Health
Rachel Civen, MD, MPH (speaker)
Medical Epidemiologist, Vectorborne Disease Unit, Acute Communicable Disease Control Program, Los Angeles County Department of Public Health
Neil Silverman, MD (speaker)
Clinical Professor, Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, David Geffen School of Medicine at UCLA
Upon completion of this activity, participants will be able to:
- Describe the clinical manifestations of Zika and impacts of infection in pregnant women
- Identify four modes of transmission and their relative importance
- Describe what groups should be tested for Zika infection and what lab specimens should be submitted for testing
- Name three measures to prevent infection for a traveler to a country with ongoing Zika transmission
- Identify two actions that Los Angeles County residents can take to reduce the risk of Zika transmission
- Discuss the importance of cultural-linguistically tailored outreach and counseling to communities at highest risk of travel related Zika virus infections.
Laurene Mascola, MD, MPH, FAAP
Dr. Mascola is Chief of the Acute Communicable Disease Control Program for the Los Angeles County (LAC) Department of Public Health. Her program focuses on disease surveillance, investigation and control for more than 80 diseases and syndromes in an area of over 4,000 square miles with 10 million people. It consists of Outbreak Investigation Section, Epidemiology and Data Support Section, Hospital Outreach Unit, Food Safety Unit, Bloodborne Pathogens Unit and Automated Disease Surveillance Section. She attended St. Louis University Medical School and earned her Masters of Public Health from the UCLA. She completed her pediatric residency at CHLA and completed residency and fellowship programs in Preventive Medicine. She is a pediatrician and a member of the Alpha Omega Alpha Medical Honor Society. She served as an Epidemic Intelligence Service Officer in the Division of Venereal Disease Control at the CDC and was a field officer in LAC. She worked internationally for the WHO in Ethiopia, and she has provided consultations in Brazil, Nepal and Mongolia.
Dr. Mascola has extensive experience in epidemiology and infectious disease prevention and control; publishing more than 100 articles, abstracts and book chapters. Dr. Mascola is a recipient of many honors and awards, including CDC Charles C. Shepard Science Awards, a Certificate of Appreciation from the FDA and the AAP’s Outstanding Achievement Award from the Council on Community Pediatrics and the Section on Epidemiology in 2009. She has been a member of Council of State and Territorial Epidemiologists (CSTE) for the last 9 years. In the summer of 2009, she was elected by CSTE to be the Infectious Disease Chair and became President-elect in 2011. In 2013, she was a Vice President of CSTE. She is also a member of the Board of Scientific Counselors, Office of Infectious Diseases, CDC.
Neil Silverman, MD
Dr. Silverman currently practices at the Center for Fetal Medicine and Women’s Ultrasound in Los Angeles, where he provides consultative care for high-risk obstetric patients on a daily basis. As a Clinical Professor in the Department of Obstetrics and Gynecology/Division of Maternal-Fetal Medicine at the David Geffen School of Medicine at UCLA, he also trains and supervises research with residents and fellows from UCLA’s OBGYN department.
Dr. Silverman has authored almost 50 peer-reviewed manuscripts, 20 textbook chapters, and lectured around the country, with particular interests in obstetric infectious diseases, recurrent pregnancy loss and thrombophilias, and prenatal diagnosis. Nationally, Dr. Silverman currently serves on the Executive Council of the Infectious Diseases Society for Obstetrics and Gynecology. He recently completed a 5-year service on ACOG’s Practice Bulletin Committee for Obstetrics, serving as committee chair from 2011-2013, and is a named primary or senior author or editor on 4 current Bulletins. He has also served on the Publications Committee for the Society for Maternal-Fetal Medicine (SMFM), has recently completed a 3-year term as an elected member to its Board of Directors, and is the Society’s current liaison member to ACOG’s Committee on Ethics. In addition, he serves as an examiner for both general and MFM oral certification boards for the American Board of Obstetrics and Gynecology.
Rachel Civen, MD, MPH
Dr. Rachel Civen has been a Medical Epidemiologist with the Acute Communicable Disease Control Program (ACDC) within the Los Angeles County (LAC) Department of Public Health (DPH), for nearly 14 years. Within ACDC, Dr. Civen currently directs the surveillance for vector-borne diseases, hepatitis, invasive meningococcal disease and neurological infections. She is board certified in infectious diseases, internal medicine and preventive medicine. Dr. Civen has authored 25 peer-reviewed manuscripts in a variety of communicable disease topics to include: the epidemiology of varicella disease and herpes zoster since the adoption of varicella vaccination in the US, West Nile virus and murine typhus surveillance and a variety of instructive outbreak investigations. Prior coming to the LAC DPH, Dr. Civen served as the Tuberculosis Controller for Alameda County and worked as an infectious disease specialist in private practice and for Kaiser Permanente Medical Group.
This activity targets all Los Angeles County physicians-particularly family practice, internal medicine, obstetrics-gynecology, perinatology, urgent care, and emergency medicine specialties. All health care professionals who may counsel/evaluate pregnant women considering travel to or returning from travel to Zika-affected countries and who may care for anyone who may present with illness following travel are strongly encouraged to attend.
The Los Angeles County Department of Public Health is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.
Physicians: The Los Angeles County Department of Public Health is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. The Los Angeles County Department of Public Health designates this live activity for a maximum of [ 1 ]
AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Nurses receive a Certificate of attendance. This activity is designated for [1 ]
AMA PRA Category 1 Credit(s)™ . According to the California Board of Registered Nursing, the Continuing Medical Education is acceptable for meeting RN continuing education requirements, as long as the course is Category 1, and has been taken within the appropriate time frames.
This activity is offered by an accredited CMA-CME provider and is not commercially supported. None of the speakers or planners have disclosed any financial interests related to the content of the webinar.
For questions or further information, please contact: Disly Juarez, MPH, 213-989-7236,